AstraZeneca, a prominent global pharmaceutical firm, has achieved prestigious certifications as a Top Employer and Best Place to Work in key African markets.
This recognition is a significant milestone, with Nigeria securing its first-ever Top Employer certification, solidifying AstraZeneca’s leadership position in the country’s healthcare sector.
AstraZeneca has also maintained its status as a Top Employer for the fourth consecutive year in South Africa and Kenya. Additionally, the company has been recognized with the Best Places to Work certification in Ivory Coast, Cameroon, and Senegal, highlighting its commitment to nurturing talent and creating an inclusive workplace environment.
Deepak Arora, Country President of the African Cluster at AstraZeneca, emphasizes that these achievements acknowledge the company’s commitment to Environmental, Social, and Corporate Governance efforts.
“Our recent certifications reaffirm our dedication to upholding the highest standards in people practices and fostering an inclusive, supportive, and innovative workplace culture and environment. We are particularly proud of our pioneering achievement in Nigeria, where we continue to lead the way in setting industry benchmarks for workplace excellence. These developments reflect our social commitment to a sustainable workplace environment for growth”.
He emphasizes their dedication to maintaining the highest standards in people practices and cultivating an inclusive and innovative workplace culture.
AstraZeneca’s success in obtaining the Top Employer Certification stems from its continuous dedication to excellence across six key HR domains and 20 topics, including People Strategy, Work Environment, Talent Acquisition, Learning, Diversity, Equity & Inclusion, and Wellbeing.
The Best Place to Work program evaluates organizations’ attractiveness through a comprehensive assessment process, focusing on eight workplace factors: culture, leadership, growth opportunities, and people practices.
READ ALSO...
Shelleny Govender, AstraZeneca’s Human Resource Director for the African Cluster, expresses gratitude for these recognitions, highlighting the company’s commitment to maintaining high working standards across diverse regions.
AstraZeneca’s longstanding commitment to medical innovation, coupled with its diverse portfolio of life-changing drugs in therapeutic areas such as oncology, cardiovascular, and respiratory diseases, underscores its pivotal role in addressing global health challenges.
Through collaborations and initiatives aimed at improving global health outcomes, AstraZeneca continues to leverage cutting-edge science and technology to advance healthcare interventions.
